Bhekisisa, who have broken many of the major HIV-funding developments since January 2024, speak to Mitchell Warren, the executive director of Avac, a New York-based HIV advocacy organisation

We talked to experts in obesity, tobacco, AI, HIV, TB and the NHI to find out what we can expect — and what we can’t — this year

Twenty-five years ago, South Africans battled for ARVs to keep people alive. Now the focus has shifted to medicines that can prevent HIV altogether. Health Beat looks how the story has evolved

What’s driving anti-immigrant healthcare blockades? Sharon Ekambaram says it’s everything from the sky-high cost of Zimbabwean passports and corruption to South Africa’s institutionalised xenophobia — and a growing global intolerance of migrants

The first batch of lenacapavir shots, a new six-monthly anti-HIV injection, should ‘be managed strategically’, said health minister Aaron Motsoaledi in October. But who should get what slice of the pie once the medicine is available in public clinics?

The government says it could fill the potential gap in the number of doses to end Aids by 2043 by getting a group of local pharmaceutical companies to make generic shots from 2027 onwards